Search | Clinical Trials Finder

Independent directory Public ClinicalTrials.gov records United States

ClinicalTrials.gov public records Last synced Sep 14, 2026, 7:51 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–48 of 24 matching trials from the live ClinicalTrials.gov search.

Local D1 index available.

Filters: Intervention: Genotropin Clear all

Conditions: Growth Hormone Deficiency
Interventions: Growth hormone; Drug
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2025
U.S. locations: 1
States / cities: New York, New York

Conditions: Idiopathic Short Stature
Interventions: Vosoritide Injection, Human Growth Hormone, Placebo; Drug
Lead sponsor: BioMarin Pharmaceutical; Industry
Eligibility: 3 Years to 11 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2036
U.S. locations: 35
States / cities: California City, California • Los Angeles, California • Oakland, California + 28 more

Conditions: Growth Hormone Deficiency, Idiopathic Short Stature
Interventions: New Genotropin Pen; Device
Lead sponsor: Pfizer; Industry
Eligibility: 8 Years to 18 Years
Enrollment: 136 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 25
States / cities: Los Angeles, California • San Diego, California • Greenwood Village, Colorado + 18 more

Conditions: Obesity, Prader Willi Syndrome
Interventions: High carbohydrate meal, High fat meal; Other
Lead sponsor: Duke University; Other
Eligibility: 5 Years to 17 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2005
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Human Immunodeficiency Virus-Associated Adipose Redistribution Syndrome
Interventions: Serostim; Biological
Lead sponsor: EMD Serono; Industry
Eligibility: 18 Years and older
Enrollment: 126 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 25
States / cities: Birmingham, Alabama • Los Angeles, California • Palm Beach, California + 18 more

Conditions: End Stage Renal Disease
Interventions: nutritional supplement, recombinant human growth hormone (rcGH), exercise; Dietary Supplement · Drug · Behavioral
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1998 – 2006
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Growth Hormone Insensitivity Syndrome (GHIS), Laron Syndrome
Interventions: rhIGF-I/rhIGFBP-3; Drug
Lead sponsor: Insmed Incorporated; Industry
Eligibility: 2 Years to 18 Years
U.S. locations: 1
States / cities: New York, New York

Conditions: Non-Alcoholic Fatty Liver Disease, Obesity, Obesity, Abdominal, Liver Fat, Fatty Liver
Interventions: Tesamorelin, Identical Placebo; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 65 Years
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Growth Hormone Disorder, Growth Hormone Deficiency in Children
Interventions: somatropin; Drug
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 3 Years to 17 Years
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2003
U.S. locations: 21
States / cities: Los Angeles, California • Wilmington, Delaware • Washington D.C., District of Columbia + 15 more

Conditions: Burns, Growth Hormone Treatment
Interventions: Somatropin, 0.09% Saline Solution; Drug
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: 18 Years to 85 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2021
U.S. locations: 1
States / cities: Galveston, Texas

Conditions: Normal Cellular Metabolism
Interventions: Somatostatin, Glucagon; Drug
Lead sponsor: K. Sreekumaran Nair; Other
Eligibility: 18 Years to 45 Years
Enrollment: 17 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Acromegaly
Interventions: Octreotide capsules; Drug
Lead sponsor: Chiasma, Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 155 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Growth Hormone Disorder, Adult Growth Hormone Deficiency
Interventions: somapacitan, somatropin, placebo; Drug
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 23 Years to 79 Years
Enrollment: 301 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 29
States / cities: Birmingham, Alabama • Los Angeles, California • Aurora, Colorado + 23 more

Conditions: Turner Syndrome
Interventions: estrogen, androgen, placebo; Drug · Other
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 10 Years to 14 Years · Female only
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1992 – 2012
U.S. locations: 2
States / cities: Bethesda, Maryland • Philadelphia, Pennsylvania

Conditions: Obesity, Metabolic Syndrome, Impaired Glucose Tolerance
Interventions: Recombinant human growth hormone; pioglitazone; Drug
Lead sponsor: Stanford University; Other
Eligibility: 40 Years to 75 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2005
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Primary Insulin-like Growth Factor-1 Deficiency
Interventions: mecasermin [rDNA origin] injection; Biological
Lead sponsor: Ipsen; Industry
Eligibility: Not listed
Enrollment: 1,378 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2014
U.S. locations: 1
States / cities: Basking Ridge, New Jersey

Conditions: Growth Failure, X-linked Severe Combined Immunodeficiency (XSCID), Growth Hormone Resistence
Interventions: Increlex; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 2 Years to 20 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2012
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Elderly
Interventions: GHRH; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 65 Years to 85 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 2
States / cities: Baltimore, Maryland • Boston, Massachusetts

Conditions: Constitutional Growth Delay, Nutrition Disorders, Growth Disorders
Interventions: Pediasure, GH; Drug
Lead sponsor: Nemours Children's Clinic; Other
Eligibility: 7 Years to 10 Years · Male only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2010
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Acromegaly
Interventions: Somatuline Autogel (lanreotide acetate), Home administration; Drug · Behavioral
Lead sponsor: Ipsen; Industry
Eligibility: 18 Years and older
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 13
States / cities: La Mesa, California • Los Angeles, California • Denver, Colorado + 8 more

Conditions: Growth Hormone Deficiency
Interventions: Growth Hormone; Drug
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: New York, New York

Conditions: Growth Disorder, Growth Hormone Deficiency in Children
Interventions: No treatment given; Other
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 4 Years to 13 Years
Enrollment: 252 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 24
States / cities: Phoenix, Arizona • Centennial, Colorado • Wilmington, Delaware + 20 more

Conditions: Osteogenesis Imperfecta
Interventions: Humatrope; Drug
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 3 Years to 16 Years
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1991 – 2017
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Chronic Kidney Disease, Kidney Disease
Interventions: MK-0677, Placebo; Drug
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years to 85 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Charlottesville, Virginia